Motion-corrected free-breathing LGE delivers high quality imaging and reduces scan time by half: an independent validation study.
Adult
Aged
Contrast Media
/ administration & dosage
Efficiency, Organizational
Female
Fibrosis
Heart Diseases
/ diagnostic imaging
Humans
Magnetic Resonance Imaging, Cine
Male
Meglumine
/ administration & dosage
Middle Aged
Myocardium
/ pathology
Organometallic Compounds
/ administration & dosage
Predictive Value of Tests
Reproducibility of Results
Tertiary Care Centers
Time Factors
Ventricular Function, Left
Workflow
Cardiac imaging
Fibrosis
Image quality
Late gadolinium enhancement
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
15
02
2019
accepted:
06
05
2019
pubmed:
20
5
2019
medline:
4
12
2019
entrez:
20
5
2019
Statut:
ppublish
Résumé
Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) sequences have evolved. Free-breathing motion-corrected (MOCO) LGE has potential advantages over breath-held (bh) LGE including minimal user input for the short axis (SAX) stack without breath-holds. It has previously been shown that MOCO-LGE delivers high image quality compared to bh-LGE. We sought to conduct an independent validation study to investigate real-world performance of bh-LGE versus MOCO-LGE in a high-throughput CMR center immediately after the introduction of the MOCO-LGE sequence and with elementary staff induction in its use. Four-hundred consecutive patients, referred for CMR and graded by clinical complexity, underwent CMR on either of two scanners (1.5 T, both Siemens) in a UK tertiary cardiac center. Scar imaging was by bh-LGE or MOCO-LGE (both with phase sensitive inversion recovery). Image quality, scan time, reader confidence and report reproducibility were compared between those scanned by bh-LGE versus MOCO-LGE. Readers had > 3 years CMR experience. Categorical variables were compared by χ
Identifiants
pubmed: 31104178
doi: 10.1007/s10554-019-01620-x
pii: 10.1007/s10554-019-01620-x
pmc: PMC6773664
doi:
Substances chimiques
Contrast Media
0
Organometallic Compounds
0
Meglumine
6HG8UB2MUY
gadoterate meglumine
L0ND3981AG
Types de publication
Comparative Study
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1893-1901Subventions
Organisme : British Heart Foundation
ID : FS/10/40/28260
Pays : United Kingdom
Organisme : EACVI
ID : 2016
Références
J Cardiovasc Magn Reson. 2003 Jul;5(3):505-14
pubmed: 12882082
Circ Cardiovasc Imaging. 2013 May 1;6(3):423-32
pubmed: 23599309
J Cardiovasc Magn Reson. 2013 Jun 20;15:55
pubmed: 23787094
J Magn Reson Imaging. 2007 Jul;26(1):184-90
pubmed: 17659545
Radiology. 2008 Apr;247(1):106-14
pubmed: 18292473
Acad Radiol. 2007 Dec;14(12):1500-8
pubmed: 18035279
J Magn Reson Imaging. 2012 Sep;36(3):529-42
pubmed: 22903654
J Cardiovasc Magn Reson. 2008 Jul 07;10:35
pubmed: 18605997
Circ Cardiovasc Imaging. 2018 Jun;11(6):e007168
pubmed: 29853467
Med Image Anal. 2018 Dec;50:82-94
pubmed: 30227385
Magn Reson Med. 2015 Mar;73(3):1015-25
pubmed: 24687458
Magn Reson Med. 2005 Jan;53(1):194-200
pubmed: 15690519
Magn Reson Med. 2002 Feb;47(2):372-83
pubmed: 11810682
Acta Radiol. 2010 May;51(4):368-74
pubmed: 20350244